Cell MedX Corp (CMXC)
0.043
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Cell MedX Enterprise Value: 13.02M for June 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
June 14, 2024 | 13.02M |
June 13, 2024 | 11.54M |
June 12, 2024 | 11.54M |
June 11, 2024 | 11.54M |
June 10, 2024 | 11.54M |
June 07, 2024 | 13.32M |
June 06, 2024 | 13.32M |
June 05, 2024 | 9.159M |
June 04, 2024 | 13.32M |
June 03, 2024 | 7.227M |
May 31, 2024 | 13.62M |
May 30, 2024 | 7.227M |
May 29, 2024 | 7.227M |
May 28, 2024 | 7.227M |
May 24, 2024 | 7.227M |
May 23, 2024 | 7.138M |
May 22, 2024 | 7.138M |
May 21, 2024 | 6.871M |
May 20, 2024 | 14.21M |
May 17, 2024 | 6.484M |
May 16, 2024 | 6.484M |
May 15, 2024 | 6.484M |
May 14, 2024 | 6.484M |
May 13, 2024 | 6.514M |
May 10, 2024 | 6.514M |
Date | Value |
---|---|
May 09, 2024 | 9.754M |
May 08, 2024 | 9.457M |
May 07, 2024 | 9.457M |
May 06, 2024 | 9.159M |
May 03, 2024 | 9.159M |
May 02, 2024 | 6.782M |
May 01, 2024 | 6.782M |
April 30, 2024 | 6.782M |
April 29, 2024 | 6.782M |
April 26, 2024 | 9.754M |
April 25, 2024 | 9.754M |
April 24, 2024 | 13.02M |
April 23, 2024 | 10.65M |
April 22, 2024 | 11.24M |
April 19, 2024 | 14.51M |
April 18, 2024 | 14.51M |
April 17, 2024 | 14.51M |
April 16, 2024 | 14.51M |
April 15, 2024 | 9.159M |
April 12, 2024 | 9.084M |
April 11, 2024 | 9.084M |
April 10, 2024 | 9.084M |
April 09, 2024 | 9.084M |
April 08, 2024 | 9.084M |
April 05, 2024 | 9.084M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.8614M
Minimum
Mar 24 2023
78.59M
Maximum
Sep 17 2019
12.79M
Average
10.50M
Median
Jan 07 2022
Enterprise Value Benchmarks
Perspective Therapeutics Inc | 487.28M |
Electromed Inc | 113.97M |
Xtant Medical Holdings Inc | 120.34M |
Asensus Surgical Inc | 81.88M |
Senseonics Holdings Inc | 160.98M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 0.12M |
Total Expenses (Quarterly) | 0.0578M |
EPS Diluted (Quarterly) | 0.0005 |
Earnings Yield | -3.82% |
Normalized Earnings Yield | -15.36 |